Bio Protocol completes $6.9 million seed round financing, led by Arthur Hayes' Maelstrom Fund

BlockBeats News, September 17, Bio Protocol has completed a $6.9 million seed round led by Arthur Hayes' Maelstrom Fund. Mechanism Capital, Animoca Brands, Zee Prime Capital, Panga Capital, Mirana Ventures, Foresight Ventures, Big Brain Holdings, and others also participated.

Bio Protocol will launch an AI-based decentralized science platform for biotechnology financing and drug discovery. This fundraising coincides with the launch of Bio V2, which introduces on-chain fundraising and a decentralized AI-driven framework for early-stage scientific research and development. Researchers, patients, and the crypto community can use BioAgents to generate scientific hypotheses, monetize discoveries, and more rapidly uncover hidden insights in biology, surpassing traditional biotechnology. Bio plans to globally expand the BioAgent framework to other researchers and laboratories, creating a decentralized scientific machine network to build and monetize biotechnology research outside of traditional pharmaceutical structures.

Arthur Hayes stated that Bio is about to become a category-defining launch platform that will fund scientific research deemed attractive by the community, not just academia. If successful, this is not only a launch platform—it is also the birth of an AI-native research marketplace.